Related news from
Tue, 11 Dec 2018 13:29:01 +0000	HCP Prices Upsized Public Offering of 15M Common Shares HCP increases public offering of common stock to 15 million shares, and enters into a forward sale agreement for 13 million shares as well.
Tue, 11 Dec 2018 02:32:00 +0000	HCP Upsizes and Prices Public Offering of 15,000,000 Shares of Common Stock IRVINE, Calif., Dec. 10, 2018 /PRNewswire/ -- HCP, Inc. (HCP) (the "Company") announced today that it has agreed to sell 15,000,000 shares of its common stock, consisting of 2,000,000 shares offered directly by the Company and 13,000,000 shares offered on a forward basis in connection with the forward sale agreement described below, at a price of $28.90 per share (before deducting underwriting discounts and commissions).  The 15,000,000 share offering represents a 1,000,000 share upsize to the originally proposed 14,000,000 share offering.  The forward purchaser (as described below) has also granted the underwriters a 30-day option to purchase up to an additional 2,250,000 shares of the Company's common stock. BofA Merrill Lynch is acting as lead book-runner and Citigroup, RBC Capital Markets and UBS Investment Bank are acting as additional book-runners for this offering.
Mon, 10 Dec 2018 21:14:00 +0000	HCP Announces Public Offering of Common Stock IRVINE, Calif., Dec. 10, 2018 /PRNewswire/ -- HCP, Inc. (HCP) (the "Company") announced today that it has commenced a public offering of an aggregate of 14,000,000 shares of its common stock, consisting of 2,000,000 shares offered directly by the Company and 12,000,000 shares offered on a forward basis in connection with the forward sale agreement described below.  The forward purchaser (as described below) expects to grant the underwriters a 30-day option to purchase up to an additional 2,100,000 shares of the Company's common stock. BofA Merrill Lynch is acting as book-runner for this offering.
Fri, 30 Nov 2018 14:31:02 +0000	HCP (HCP) Up 2.4% Since Last Earnings Report: Can It Continue? HCP (HCP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Fri, 30 Nov 2018 12:00:00 +0000	Is It Time to Buy These Beaten-Up Bargains in Healthcare? The stock market's November swoon has put these top healthcare stocks on sale.
Thu, 29 Nov 2018 20:12:00 +0000	Is This Healthcare REIT Best for Dividends? A restructuring is positioning HCP for a recovery.
Fri, 23 Nov 2018 19:43:55 +0000	How To Look At HCP Inc (NYSE:HCP) HCP Inc is a US$14b large-cap, real estate investment trust (REIT) based in Irvine, United States. REITs are basically a portfolio of income-producing real estate investments, which are owned and<div><a class="permalink" href="https://simplywall.st/news/yahoo-post/how-to-look-at-hcp-inc-nysehcp/">Read More...</a></div>
Mon, 19 Nov 2018 22:41:53 +0000	Stocks Barrow, Hanley, Mewhinney & Strauss Keeps Buying Barrow, Hanley, Mewhinney & Strauss, which serves as a subadvisor to more than 45 equity and fixed-income mutual funds, bought shares of the following stocks in both the second and third quarters. Warren Buffett (Trades, Portfolio) is the largest shareholder of the company among the gurus with 6.55% of outstanding shares, followed by Dodge & Cox 4.64%, First Eagle Investment (Trades, Portfolio) with 1.93% and Chris Davis (Trades, Portfolio) with 1.77%. The company's largest guru shareholder is First Pacific Advisors (Trades, Portfolio) with 0.49% of outstanding shares, followed by Spiros Segalas (Trades, Portfolio) with 0.46%, Steven Romick (Trades, Portfolio) with 0.38% and Barrow, Hanley, Mewhinney & Strauss with 0.32%.
Fri, 16 Nov 2018 14:30:02 +0000	HPT vs. HCP: Which Stock Should Value Investors Buy Now? HPT vs. HCP: Which Stock Is the Better Value Option?
Tue, 13 Nov 2018 13:01:22 +0000	See what the IHS Markit Score report has to say about HCP Inc. HCP Inc NYSE:HCP
Thu, 08 Nov 2018 22:34:25 +0000	Eyeing faster path for sickle cell drug, Peninsula biotech plots expansion — for a higher price One of the first tenants in The Cove at Oyster Point is taking the last building in the South San Francisco development as rents in the region hit new highs.
Tue, 06 Nov 2018 12:40:00 +0000	Report: Developing Opportunities within Stryker, Anavex Life Sciences, Engility, Baker Hughes, a GE company, GlycoMimetics, and HCP — Future Expectations, Projections Moving into 2018 NEW YORK, Nov. 06, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Fri, 02 Nov 2018 22:17:13 +0000	Edited Transcript of HCP earnings conference call or presentation 31-Oct-18 4:00pm GMT Q3 2018 HCP Inc Earnings Call
Thu, 01 Nov 2018 11:33:00 +0000	How Safe Are HCP and Its Dividend? This REIT has a massive 5.4% yield, but is it sustainable?
Thu, 01 Nov 2018 00:14:18 +0000	HCP Inc (HCP) Q3 2018 Earnings Conference Call Transcript HCP earnings call for the period ending September 30, 2018.
Wed, 31 Oct 2018 13:23:00 +0000	HCP Upgraded by S&P Global Ratings to BBB+ with Stable Outlook IRVINE, Calif. , Oct. 31, 2018 /PRNewswire/ -- HCP, Inc. (NYSE: HCP) today announced that S&P Global Ratings ("S&P") upgraded its corporate credit rating to BBB+ from BBB, with a stable outlook. ...
Wed, 31 Oct 2018 13:15:01 +0000	HCP (HCP) Surpasses Q3 FFO Estimates HCP (HCP) delivered FFO and revenue surprises of 2.33% and -0.31%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
Wed, 31 Oct 2018 13:12:01 +0000	HCP Tops Q3 FFO Estimates on NOI Growth, Misses on Revenues HCP's third-quarter performance indicates year-over-year growth in three-month cash SPP net operating income (NOI) for the company's total portfolio.
Wed, 31 Oct 2018 12:07:22 +0000	HCP: 3Q Earnings Snapshot The Irvine, California-based real estate investment trust said it had funds from operations of $208.2 million, or 44 cents per share, in the period. The average estimate of 11 analysts surveyed by Zacks ...

If you are already a Value Forum member but are not logged on, click here to log on. If you are a guest, thank you for visiting ValueForum -- click here for information about guest access or click here to join -- a Trial Pass can be purchased for $6.99 to help you decide if you want to commit to longer term membership. Did you know there are customized portals into VF like REITs.ValueForum.com and also My ValueForum which lets you customize your VF experience to the posters and topics that most interest you!